countries. 8 This food-borne disease is transmitted via the fecal-oral route after digestion of contaminated food products and water and is considered as a public health challenge especially in terms of food safety due to its ability to grow at 4°C. 9 In immunocompetent hosts, the bacterium causes local infection in the gastrointestinal tract, which is characterized as a mild and self-limiting diarrhea. However, antimicrobial therapy is required in immunocompromised patients due to the risk of systemic infection with a high mortality rate (50%). 4, 6, 7, 9 Because of the high bacterial susceptibility to broad-spectrum cephalosporins, aminoglycosides, chloramphenicol, tetracyclines, trimethoprim/sulfamethoxazole and ciprofloxacin, these drugs are recommended by the World Health Organization (WHO) for treatment of human invasive infections caused by Y. enterocolitica. 2, 9 However, some of these antibiotics have also been used for growth promotion, prophylaxis, and treatment in food-producing animals, which has led to the emergence of antimicrobial-resistant strains followed by transferring these antimicrobial-resistant food-borne pathogens to humans. 10 Hitherto, there has been no comprehensive information about the epidemiology of antibioticresistant Yersinia species in Iran. Therefore, the aim of this systematic review and meta-analysis was to investigate the antimicrobial susceptibility profiles of Yersinia species, especially Y. enterocolitica among non-clinical and clinical isolates in Iran.
Materials and Methods Data Sources and Search Strategies
The study protocol was in accordance with PRISMA (the Preferred Reporting Items for Systematic Review and Meta-Analysis) checklist. 11 The main sources of data to investigate the prevalence of antimicrobial susceptibility profiles of Yersinia species in Iran in international and national databases were PubMed (https://www.ncbi. nlm.nih.gov), Scopus (https://www.scopus.com), Google Scholar (http://scholar.google.com), and the Scientific Information Database (SID) (www.sid.ir). Using some major keywords, i.e., "antibiotic resistance", "Yersinia", "Iran" and with the help of boolean operators (AND and OR) and the truncation mark (*), a complete search was performed in databases until June 10, 2019 followed by a supplementary literature search in the reference lists of included articles to identify eligible studies for the metaanalysis.
Screening of Studies and Selection Criteria
Collected records during literature search process were further evaluated for eligibility based on the inclusion and exclusion criteria. To start, duplicate records were removed through screening of titles. Then, the abstracts and full texts were screened by two investigators independently according to the inclusion criteria. Persian-and Englishlanguage articles containing sufficient and extractable data and studies focusing on antibiotic resistance rate of Yersinia species only in Iran were included in the study. Records other than cross-sectional studies, food and clinical specimens and Yersinia species, incomplete data and duplicate publications were excluded from the metaanalysis.
Data Extraction and Quality Assessment of Studies
A full-text review of articles meeting eligibility criteria was done in order to extract data and perform quality assessment of studies. Data were extracted for each study and sorted by first author details, area of the study, year of the study, type and number of Yersinia species isolated from different specimens, origin of samples, antibiotic susceptibility test methods and number of resistant Yersinia isolates for each species. Then, the quality of included studies was assessed using the Joanna Briggs Institute (JBI) checklist presented by Munn et al for studies reporting prevalence data. 12 The JBI checklist contained some items about the target population, sample size, statistical analysis, and methods used for the identification, and eligible studies receiving more than 5 scores were considered as high-quality, 4-5 scores as medium-quality and lower than 4 scores as low-quality studies ( Table 1) .
Data Processing and Analysis
All statistical analyses were performed using the CMA (Comprehensive Meta-Analysis) software, version 2.2 (Biostat, Englewood, NJ). The resistance rates of Yersinia species among included studies were determined using forest plots of pooled event rates and expressed as percentage and 95% confidence intervals (CIs). Subgroup analysis was done based on type of Yersinia species. Data analysis and synthesis were done by combining at least four studies. Depending on the existence of heterogeneity among included studies, data on the antibiotic resistance were pooled using random-or fixed-effects models. Heterogeneity degree of the studies was determined with the help of the I 2 statistic (25% (low), 50% (moderate), and 75% (high)) and the Chi-square test with Cochran's Q statistic (significant at P < 0.1). A potential publication bias in articles reporting resistance rate for each antibiotic was investigated through visually observation of symmetry in funnel plots. Figure 1 , a total of 12 studies were selected for meta-analysis among 1019 identified citations through database searching. Y. enterocolitica (61.3%), Y. frederiksenii (12.2%) and Y. intermedia (6.1%) were the most common species of the genus Yersinia and their antibiotic resistance rates was investigated in the included articles through disk diffusion method in Iran. Additionally, Y. enterocolitica strains were isolated from both non-clinical and clinical samples, while Y. Table 1 , eligible studies were from Ahvaz, Behshahr, Fuladshahr, Hamadan, Qom and Tehran with quality scores of ≥5. We assessed the resistance prevalence of Yersinia species and the potential publication bias for each antibiotic using forest plots (Figures 2A, B and C) and funnel plots ( Figures 3A, B and C), respectively. Overall resistance prevalence of Yersinia species against selected antimicrobial agents that were isolated from food products and clinical specimens in Iran was as follows: 22.4% (95% CI: 4.8-62.3; I 2 = 88.7%; Q = 53.1; P = 0.00) to amoxicillin, 41.9% (95% CI: 29-56.1; I 2 = 71.9%; Q = 49.8; P = 0.00) to ampicillin, 6% (95% CI: 2.8-12.4; I 2 = 30.8%; Q = 23.1; P = 0.11) to gentamicin, 17% (95% CI: 10.5-26.3; I 2 = 0.0%; Q = 7.8; P = 0.44) to trimethoprim/sulfamethoxazole, 19% (95% CI: 11.8-29.2; I 2 = 58.8%; Q = 33.9; P = 0.00) to tetracycline, 10.3% (95% CI: 3.6-26.2; I 2 = 80.8%; Q = 78.2; P = 0.00) to ciprofloxacin, 10.5% (95% CI: 7-15.3; I 2 = 0.0%; Q = 8.3; P = 0.76) to streptomycin, 3.8% (95% CI: 1.9-7.6; I 2 = 0.0%; Q = 5; P = 0.98) to chloramphenicol, 79.3% (95% CI: 60.6-90.5; I 2 = 80.4%; Q = 76.7; P = 0.00) to cephalothin, 18.4% (95% CI: 13.9-23.9; I 2 = 11.1%; Q = 14.6; P = 0.33) to nalidixic acid, 6.6% (95% CI: 1.9-20.8; I 2 = 39.9%; Q = 11.6; P = 0.11) to cefotaxime and 12.2% (95% CI: 8.1-17.9; I 2 = 0.0%; Q = 6; P = 0.64) to trimethoprim. Finally, we performed a subgroup analysis of antibiotic resistance profile of Yersinia species against selected antibiotics ( Table 2 ).
Results

As shown in
Discussion
Our study on the prevalence of antibiotic-resistant Yersinia species in both food products and clinical samples in Iran showed high resistance rates against amoxicillin (22.4%), ampicillin (41.9%), trimethoprim/sulfamethoxazole (17%), tetracycline (19%), cephalothin (79.3%), nalidixic acid (18.4%), and trimethoprim (12.2%). In contrast, low resistance rates against gentamicin (6%), ciprofloxacin (10.3%), streptomycin (10.5%), chloramphenicol (3.8%), and cefotaxime (6.6%) were found. Among Yersinia species, Y. enterocolitica was the most common species in the present study. Pigs are considered as the most important source of human Y. enterocolitica infection in the world. 9 However, for religious reasons, pigs are not used in Iran and as shown in Table 1 , milk, chicken and beef were the main sources of Y. enterocolitica in Iran. 20 Given that these kinds of food products are important sources of nutrients for Iranian people, there is a high risk of the outbreak of Y. enterocolitica-induced enteric infections associated with the consumption of contaminated food products in Iran. On the other hand, in this study, the prevalence of Y. enterocolitica strains isolated from the clinical samples was low. Studies have reported that clinical Y. enterocolitica infections were relatively infrequent in Iran, which can be explained by fact that Yersinia species are not routinely screened in most clinical laboratories. 14, 20 Therefore, improving identification procedures for Y. enterocolitica from different samples is necessary to determine the epidemiology of this microorganism. However, a more important issue is excessive administration of some antibiotics, i.e., tetracycline and ciprofloxacin for growth promotion, disease prevention and treatment of diseases in animals in Iran. This excessive use results in the emergence of antibiotic-resistant strains. 20, 23 Our findings indicated that the prevalence of Y. enterocolitica strains resistant to tetracycline and ciprofloxacin antibiotics in both food products and clinical samples was 18.3% and 6%, respectively. Therefore, limiting the use of these antibiotics, especially tetracycline, in food-producing animals is recommended in order to prevent the emergence of antibiotic-resistant food-borne pathogens and their transmission to humans through food products. Reported resistance prevalence of Y. enterocolitica strains isolated from food products against quinolones, ciprofloxacin and nalidixic acid, and tetracycline in different countries is as follows: Italy (0%), China (1.4% to ciprofloxacin, 18.6% to nalidixic acid, and 8.6% to tetracycline), Austria (0%), Germany (0%), Turkey (0% to ciprofloxacin, 4.8% to nalidixic acid, and 4.8% to tetracycline), Korea (0%), and Malaysia (62.5% to nalidixic acid and tetracycline). [25] [26] [27] [28] [29] [30] [31] Reports have proven the resistance of Y. enterocolitica to first-generation cephalosporins and ampicillin. 1 Similarly, the resistance of Y. enterocolitica to β-lactams including amoxicillin (45.9%), ampicillin (50.3%), and cephalothin (83.3%) was high in Iran. This high percentage of resistance can be attributed to β-lactamases A and B produced by Y. enterocolitica. 25 Similar results in accordance with our meta-analysis were observed for Y. enterocolitica strains isolated from food products in Italy (100% to ampicillin and cephalothin), China (98.6% to ampicillin and 95.7% to cephalothin), Germany (83.3% to amoxicillin, 50% to ampicillin, and 83.3% to cephalothin), Turkey (57.1% to amoxicillin, 64.3% to ampicillin, and 86.9% to cephalothin), Korea (94% to ampicillin and 100% to cephalothin) and Malaysia (92.6% to amoxicillin and 96.3% to ampicillin). 25, 26, [28] [29] [30] [31] Gentamicin in combination with either fluoroquinolones or thirdgeneration cephalosporins was recommended in lifethreatening Y. enterocolitica infections, such as sepsis and meningitis. 1, 9 Regarding aminoglycosides, gentamicin, and streptomycin, low levels of resistance have been reported among Y. enterocolitica strains isolated in Iran, which is in accordance with reports from Italy (0%), China (4.3% to gentamicin and 8.6% to streptomycin), Austria (0%), Germany (0%), Turkey (0% to gentamicin and 4.8% to streptomycin), and Korea (0%). [25] [26] [27] [28] [29] [30] The prevalence of resistance to other antibiotics used for the treatment of human yersiniosis (i.e., trimethoprim/sulfamethoxazole) was higher (17.1%) than those reported from Italy (0%) 25 and Malaysia, 31 but lower than that of China (74.3%). 26
Conclusion
Among Yersinia species, Y. enterocolitica was found as the most prevalent food-borne pathogen isolated from food products and clinical specimens in this research. Results revealed a high rate of contamination of food products and human specimens with β-lactams-resistant strains of Y. enterocolitica in Iran. Therefore, there is a risk of transmission of these antibiotic-resistant strains to humans through the consumption of food products. Furthermore, Y. enterocolitica strains in Iran were mostly susceptible to aminoglycosides, fluoroquinolone, and chloramphenicol, making these antibiotics relevant for human invasive infections. However, the present results suggested that resistance to trimethoprim/ sulfamethoxazole, tetracycline, and nalidixic acid was increasing in Iran, with a caveat of becoming a public health concern in the future. Therefore, to prevent the spread of bacterial antibiotic resistance and subsequent treatment failure, cautionary measures should be applied. These measures include (1) limiting the use of antibiotics in both animal and human (2) continuous monitoring of resistance, and (3) taking sanitary precautions such as consumption of pasteurized milk and cooked food products.
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